Premal Patel - 20 Jan 2022 Form 4 Insider Report for eFFECTOR Therapeutics, Inc.

Role
Chief Medical Officer
Signature
/s/ Michael Byrnes, Attorney-in-Fact for Premal Patel
Issuer symbol
EFTR on OTC
Transactions as of
20 Jan 2022
Net transactions value
$0
Form type
4
Filing time
24 Jan 2022, 19:05:36 UTC
Previous filing
27 Aug 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EFTR Stock Option (Right to Buy) Award $0 +150,000 $0.000000 150,000 20 Jan 2022 Common Stock 150,000 $6.65 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/48th of the total number of shares subject to the options shall vest on each monthly anniversary of January 20, 2022 (the "Vesting Commencement Date"), subject to the Reporting Person's continuous service to the Issuer on each such vesting date, so that the options shall be fully vested on the fourth anniversary of the Vesting Commencement Date.